GKB Ophthalmics Ltd
Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic
- Market Cap ₹ 49.4 Cr.
- Current Price ₹ 98.0
- High / Low ₹ 136 / 74.1
- Stock P/E
- Book Value ₹ 115
- Dividend Yield 0.00 %
- ROCE -1.19 %
- ROE -4.65 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.86 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.76% over last 3 years.
- Contingent liabilities of Rs.17.2 Cr.
- Earnings include an other income of Rs.1.36 Cr.
- Promoter holding has decreased over last 3 years: -8.63%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
42.80 | 41.45 | 35.18 | 43.76 | 76.44 | 77.93 | 57.16 | 58.53 | 56.88 | 70.94 | 75.47 | 88.25 | 97.76 | |
40.58 | 33.88 | 34.34 | 44.46 | 74.55 | 76.59 | 56.02 | 56.40 | 54.58 | 66.05 | 71.79 | 87.74 | 97.27 | |
Operating Profit | 2.22 | 7.57 | 0.84 | -0.70 | 1.89 | 1.34 | 1.14 | 2.13 | 2.30 | 4.89 | 3.68 | 0.51 | 0.49 |
OPM % | 5.19% | 18.26% | 2.39% | -1.60% | 2.47% | 1.72% | 1.99% | 3.64% | 4.04% | 6.89% | 4.88% | 0.58% | 0.50% |
0.63 | 1.09 | 1.13 | 11.72 | 3.78 | 0.49 | 2.30 | 1.11 | 1.94 | 1.21 | 0.96 | 1.51 | 1.36 | |
Interest | 2.88 | 2.86 | 2.50 | 1.63 | 1.29 | 1.27 | 1.48 | 1.46 | 2.03 | 1.48 | 1.67 | 1.90 | 2.11 |
Depreciation | 1.18 | 1.22 | 1.55 | 1.49 | 1.43 | 1.70 | 3.54 | 3.62 | 3.14 | 2.67 | 2.83 | 2.90 | 2.98 |
Profit before tax | -1.21 | 4.58 | -2.08 | 7.90 | 2.95 | -1.14 | -1.58 | -1.84 | -0.93 | 1.95 | 0.14 | -2.78 | -3.24 |
Tax % | -10.74% | 46.07% | -37.02% | 50.00% | 11.86% | -14.91% | -30.38% | 0.00% | -19.35% | 0.00% | 14.29% | 7.55% | |
-0.62 | 3.99 | 0.00 | 3.95 | 2.59 | -0.97 | -1.10 | -1.84 | -0.75 | 1.94 | 0.11 | -2.98 | -3.37 | |
EPS in Rs | -1.49 | 9.61 | 0.00 | 9.51 | 6.24 | -2.34 | -2.37 | -3.65 | -1.81 | 2.52 | -0.34 | -5.57 | -7.21 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 9% |
3 Years: | 16% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -3% |
3 Years: | % |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | 8% |
3 Years: | 4% |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | -2% |
5 Years: | -1% |
3 Years: | -1% |
Last Year: | -5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.64 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
Reserves | 30.81 | 35.74 | 35.86 | 40.66 | 42.63 | 40.79 | 50.17 | 54.21 | 57.61 | 58.06 | 57.65 | 54.73 | 53.14 |
15.09 | 12.51 | 8.62 | 7.22 | 7.19 | 9.93 | 14.07 | 15.16 | 11.97 | 11.75 | 11.22 | 11.49 | 12.35 | |
22.72 | 20.95 | 26.35 | 17.18 | 27.80 | 28.11 | 25.02 | 28.05 | 32.20 | 35.30 | 38.17 | 43.24 | 51.20 | |
Total Liabilities | 72.77 | 73.35 | 74.98 | 69.21 | 81.77 | 82.98 | 93.90 | 102.46 | 106.82 | 110.15 | 112.08 | 114.50 | 121.73 |
12.70 | 13.84 | 11.90 | 12.66 | 17.60 | 18.34 | 25.85 | 26.33 | 23.75 | 22.65 | 19.04 | 18.22 | 17.51 | |
CWIP | 2.29 | 0.57 | 0.57 | 0.57 | 0.57 | 0.24 | 0.00 | 0.00 | 1.23 | 3.41 | 3.95 | 3.91 | 3.91 |
Investments | 12.37 | 15.06 | 16.25 | 10.33 | 3.48 | 0.37 | 0.54 | 1.15 | 2.08 | 1.97 | 1.89 | 1.83 | 2.03 |
45.41 | 43.88 | 46.26 | 45.65 | 60.12 | 64.03 | 67.51 | 74.98 | 79.76 | 82.12 | 87.20 | 90.54 | 98.28 | |
Total Assets | 72.77 | 73.35 | 74.98 | 69.21 | 81.77 | 82.98 | 93.90 | 102.46 | 106.82 | 110.15 | 112.08 | 114.50 | 121.73 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.29 | 6.45 | 7.23 | -11.44 | -3.41 | -2.66 | 3.92 | 3.27 | 6.86 | 5.07 | -2.77 | 4.22 | |
-1.52 | -1.96 | -0.50 | 14.68 | 3.75 | 1.34 | -9.89 | -3.73 | -16.78 | -3.52 | 1.43 | -1.71 | |
-0.96 | -4.81 | -6.01 | -2.83 | -1.33 | 1.37 | 13.13 | 4.30 | 2.77 | -1.66 | -2.19 | -1.64 | |
Net Cash Flow | 0.81 | -0.32 | 0.72 | 0.40 | -0.99 | 0.04 | 7.16 | 3.84 | -7.15 | -0.12 | -3.53 | 0.87 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 157.17 | 185.01 | 190.70 | 142.63 | 118.04 | 128.61 | 150.32 | 155.40 | 125.00 | 100.38 | 134.16 | 117.46 |
Inventory Days | 362.01 | 344.73 | 423.86 | 284.87 | 225.01 | 223.44 | 289.19 | 301.35 | 348.75 | 306.81 | 298.31 | 244.56 |
Days Payable | 167.41 | 162.66 | 343.18 | 155.84 | 169.18 | 167.74 | 217.28 | 233.86 | 234.31 | 208.09 | 183.19 | 202.27 |
Cash Conversion Cycle | 351.78 | 367.08 | 271.38 | 271.67 | 173.87 | 184.32 | 222.23 | 222.89 | 239.45 | 199.10 | 249.28 | 159.75 |
Working Capital Days | 167.66 | 187.21 | 171.09 | 214.45 | 144.54 | 160.93 | 199.49 | 204.67 | 187.70 | 157.34 | 183.98 | 140.00 |
ROCE % | 5.17% | 13.68% | -0.18% | -1.45% | 3.32% | 0.22% | -2.49% | -0.54% | 2.76% | 4.41% | 2.22% | -1.19% |
Documents
Announcements
-
Outcome Of The Board Meeting Held On January 03, 2025 And Execution Of Loan Agreement
3 Jan - Board approved unsecured loan of Rs 5 crores.
-
Sanctioning Of Loan Amount Of Rs. 5.00 Crores By Subsidiary Company To GKB Ophthalmics Limited, Holding Company.
2 Jan - Approval of Rs. 5 Crore loan for working capital.
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
31 Dec - Director K.G. Gupta purchased 500 equity shares.
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
31 Dec - Disclosure of insider trading by Krishna Gopal Gupta & Sons.
-
Closure of Trading Window
27 Dec - Closure of trading window until financial results declaration.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39